Asosiy kontentga oʻtish
Sharh maqola

Global prevalence of kratom use: a meta-analysis focusing on regional and population-level disparities

Amr Ali Mohamed Abdelgawwad El-SehrawyDiabetes, Endocrinology and Metabolism, Internal Medicine Department, Mansoura UniversitySuleiman Ibrahim MohammadINTI International UniversityAsokan VasudevanINTI International UniversityMandeep SinghUniversity of JammuGafur AbdulakimovNational Pedagogical University of Uzbekistan named after NizamiAziza MakhmudovaSamarkand State Medical UniversityReyadh R. AL-RashidiUniversity of KutMustfa KadierChitkara UniversityMajid S. JabirCollege of Applied Sciences, University of TechnologyTina Saeed BasunduwahMedical Student, AlBatterjee Medical College
2026en

Ochiq kirish: yoʻq

ABI

Annotatsiya

This systematic review and meta-analysis synthesized prevalence data from 21 studies conducted in Southeast Asia and the United States to provide the most comprehensive estimate to date of global kratom (Mitragyna speciosa) use. The pooled prevalence was 1.6% (95% CI: 0.6%–3.8%) for current use and 3.8% (95% CI: 1.8%–7.8%) for lifetime use. Prevalence varied substantially across countries and populations, with the highest estimates observed in Thailand and among high-risk and substance-using populations. These differences likely reflect variation in cultural practices, legal frameworks, and study methodologies. Although considerable between-study heterogeneity was identified, the findings indicate that kratom use remains relatively uncommon in the general population but is substantially more prevalent among substance-using populations, highlighting the need for standardized surveillance and targeted public health strategies.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar